Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia
- PMID: 8083977
- PMCID: PMC237059
- DOI: 10.1128/JVI.68.10.6391-6400.1994
Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia
Abstract
The simian immunodeficiency virus (SIV)-rhesus macaque model of heterosexual human immunodeficiency virus transmission consists of atraumatic application of cell-free SIVmac onto the intact vaginal mucosa of mature female rhesus macaques. This procedure results in systemic infection, and eventually infected animals develop the clinical signs and pathologic changes of simian AIDS. To achieve 100% transmission with the virus stocks used to date, multiple intravaginal inoculations are required. The current titration study utilized two stocks of SIVmac and demonstrated that a single intravaginal dose of cell-free SIV can reliably produce infection in rhesus macaques. This study also demonstrated that some animals intravaginally inoculated with cell-free SIVmac develop transient viremia characterized by a limited ability to isolate virus from peripheral blood mononuclear cells and lymph node mononuclear cells and no seroconversion to SIV antigen. SIV could be isolated from the peripheral lymph nodes of transiently viremic animals only during periods of viremia and not at times when SIV was not detected in circulating mononuclear cells. Thus, peripheral lymphoid tissues were not reservoirs of infection in the transiently viremic animals. Taken together, these results suggest either that the SIV infection was cleared in the transiently viremic animals or that SIV infection is limited to a compartment of the genital mucosal immune system that cannot be assessed by monitoring SIV infection in peripheral blood mononuclear cells and peripheral lymphoid tissue.
Similar articles
-
Occult systemic infection and persistent simian immunodeficiency virus (SIV)-specific CD4(+)-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV.J Virol. 1998 Dec;72(12):10029-35. doi: 10.1128/JVI.72.12.10029-10035.1998. J Virol. 1998. PMID: 9811741 Free PMC article.
-
A period of transient viremia and occult infection precedes persistent viremia and antiviral immune responses during multiple low-dose intravaginal simian immunodeficiency virus inoculations.J Virol. 2004 Dec;78(24):14048-52. doi: 10.1128/JVI.78.24.14048-14052.2004. J Virol. 2004. PMID: 15564513 Free PMC article.
-
Effect of virus dose and nonoxynol-9 on the genital transmission of SIV in rhesus macaques.J Med Primatol. 1990;19(3-4):401-9. J Med Primatol. 1990. PMID: 2172544
-
Localization of Simian immunodeficiency virus-infected cells in the genital tract of male and female Rhesus macaques.J Reprod Immunol. 1998 Dec;41(1-2):331-9. doi: 10.1016/s0165-0378(98)00069-2. J Reprod Immunol. 1998. PMID: 10213321 Review.
-
Comparison of the vaginal environment of Macaca mulatta and Macaca nemestrina throughout the menstrual cycle.Am J Reprod Immunol. 2014 Apr;71(4):322-9. doi: 10.1111/aji.12201. Epub 2014 Feb 13. Am J Reprod Immunol. 2014. PMID: 24521395 Free PMC article. Review.
Cited by
-
Pathogenic consequences of vaginal infection with CCR5-tropic simian-human immunodeficiency virus SHIVSF162P3N.J Virol. 2012 Sep;86(17):9432-42. doi: 10.1128/JVI.00852-12. Epub 2012 Jun 27. J Virol. 2012. PMID: 22740397 Free PMC article.
-
Effect of a cellulose acetate phthalate topical cream on vaginal transmission of simian immunodeficiency virus in rhesus monkeys.Antimicrob Agents Chemother. 2000 Nov;44(11):3199-202. doi: 10.1128/AAC.44.11.3199-3202.2000. Antimicrob Agents Chemother. 2000. PMID: 11036053 Free PMC article.
-
Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA.J Virol. 2000 Feb;74(4):1767-74. doi: 10.1128/jvi.74.4.1767-1774.2000. J Virol. 2000. PMID: 10644348 Free PMC article.
-
Induction of potent local cellular immunity with low dose X4 SHIV(SF33A) vaginal exposure.Virology. 2007 Oct 10;367(1):196-211. doi: 10.1016/j.virol.2007.05.021. Epub 2007 Jun 15. Virology. 2007. PMID: 17574643 Free PMC article.
-
An antiretroviral/zinc combination gel provides 24 hours of complete protection against vaginal SHIV infection in macaques.PLoS One. 2011 Jan 5;6(1):e15835. doi: 10.1371/journal.pone.0015835. PLoS One. 2011. PMID: 21246052 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources